CN1446547A - New use in medicine for compound decoction for warming spleen of Chinese herbal medicine - Google Patents
New use in medicine for compound decoction for warming spleen of Chinese herbal medicine Download PDFInfo
- Publication number
- CN1446547A CN1446547A CN 02103810 CN02103810A CN1446547A CN 1446547 A CN1446547 A CN 1446547A CN 02103810 CN02103810 CN 02103810 CN 02103810 A CN02103810 A CN 02103810A CN 1446547 A CN1446547 A CN 1446547A
- Authority
- CN
- China
- Prior art keywords
- medicine
- wenpi decoction
- wenpi
- decoction
- extracting solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An application of Chinese medicine "compound decoction for warming spleen" in treating chronic renal failure and reducing blood-urea nitrogen and creatinine is disclosed.
Description
Technical field
The present invention relates to a kind of new purposes of known drug, particularly relate to the application of known Chinese medicine compound wenpi decoction in the medicine of preparation reduction blood urea nitrogen, creatinine levels, treatment chronic renal failure.
Background technology
Chronic renal failure betides on the various kidney diseases basis, causes nephron to be badly damaged, and goes down its prognosis extreme difference and irreversible renal function slowly occurs.Along with the development and the raising of treatment meanss such as dialysis, renal transplantation, the curative effect of end-stage renal failure has significantly improved, and has obtained the consistent of medical circle and admit.But to how postponing chronic kidney function failure early, the process in mid-term do not have substantial progress for medical circle so far.Therefore, how the process of postponing chronic kidney function failure is the focus that numerous medical circle personages pay close attention to.
Technology contents
Wenpi decoction is a kind of prescription that collects effects such as reinforcing spleen and kidney, treating coagulated cold by purgation, and this prescription is made up of Radix Et Rhizoma Rhei, Radix Aconiti Lateralis Preparata, Rhizoma Zingiberis, Radix Ginseng, Radix Glycyrrhizae etc.Existing clinical and animal experiment study shows, Radix Et Rhizoma Rhei has blood urea nitrogen in the blood samples of patients of reduction, influence the plasma free aminogram, suppress liver and kidney urea synthesis, reduce blood ammonia, and can promote proteinic synthetic, the hypertrophy that suppresses mesangial cell and renal cells suppresses the ill effect of cytokine, corrects lipid metabolic disorder, suppress the effect of immunologic injury, thereby delay the sclerosis of glomerule.Radix Ginseng induces ability to chronic kidney hypofunction patient's external T cell transformation and IL-2 all facilitation, can improve cell immune function of human body and resistance against diseases.
The object of the invention is to provide the application of wenpi decoction in the medicine of preparation reduction blood urea nitrogen, creatinine level, treatment chronic renal failure.
The present invention realizes by clinical experience and pharmacodynamic experiment research.The present invention has carried out pharmacology activity research to warming the spleen soup extract and alcohol extract.
The full side of wenpi decoction is Radix Et Rhizoma Rhei 3～20 grams; Radix Aconiti Lateralis Preparata 3～20 grams; Rhizoma Zingiberis 3～20 grams; Radix Ginseng 3～20 grams; Radix Glycyrrhizae 3～20 grams.
5～10 times of full side's waters of wenpi decoction amount decocts 2-4 time, merge the extracting solution of each time after, the cryoconcentration extracting solution, extractum, contain crude drug 2g/ml, or make dry powder, paste-forming rate is 5～15%, is wenpi decoction water extract G and organizes; The full side of wenpi decoction extracts 2～4 times with 5～10 times of amounts of 40～90% ethanol, merge the extracting solution of each time after, recovered alcohol gets extractum, contains crude drug 2g/ml, or makes dry powder, paste-forming rate is 5～15%, is wenpi decoction alcohol extract E and organizes.5～10 times of amounts of reuse water decoct 2-4 time after the alcohol extraction, merge the extracting solution of each time after, the cryoconcentration extracting solution, extractum, contain crude drug 2g/ml, or system dry powder, paste-forming rate is 5～15%, is water extract F group behind the wenpi decoction alcohol; The full side of wenpi decoction extracts 2～4 times through CO2 extraction D group, merge the extracting solution of each time after, volatilize extractum, contain crude drug 2g/ml, or make dry powder, paste-forming rate is 1～5%.
Experimental example:
Experiment purpose: observe the therapeutical effect of wenpi decoction to rat chronic renal failure (CRF) due to 5/6 nephrectomy.Method: the treatment group is taken the various different preparations of wenpi decoction, and establishes model control group, normal control group and sham operated rats, treats 3 months, observes the variation of different treatment preparation serum creatinines (SCr), blood urea nitrogen indexs such as (BUN), and the change of nephridial tissue.
1. materials and methods
1.1 100 of laboratory animal male wistar rats, body weight 165g ± 12g is provided by Chinese Academy of Medical Sciences's Experimental Animal Center.
1.2 the model preparation adopts the most of excision of 5/6 kidney to make the chronic kidney hypofunction rat model: press 0.3～0.4ml/100g lumbar injection with 10% chloral hydrate solution, after treating rat anesthesia, take lateral position, 10cm is by the otch of spinal column skidding 2～3cm under the left angle of rib, open the abdominal cavity, left kidney dissociates, with shears from the hilus renalis laterally arc cut the upper and lower utmost point, part gelfoam hemostasis by compression, see no active hemorrhage, remaining kidney on the left of resetting, intraperitoneal is placed penicillin powder, layer-by-layer suture muscle and skin then.One week is carried out the operation second time in the operation back for the first time, after the anesthesia of 10% chloral hydrate injection of solution, takes lateral position, and 10cm opens the abdominal cavity by the otch of spinal column skidding 2～3cm under the right angle of rib, the right kidney that dissociates, and the ligation kidney base of a fruit is extractd right kidney then.Should note not damaging adrenal gland and ureter during operation.Two operations is excised 5/6 of two kidney gross weights altogether, and sham operated rats adopts above same step and method, but not to left kidney and the capable excision of right kidney.
1.3 carry out random packet January after 80 wistar rats of experiment grouping were performed the operation the second time, being divided into is 8 groups.D organizes (n=12): wenpi decoction CO
2The font size group; E organizes (n=12): wenpi decoction alcohol extraction group; F organizes (n=12): water is put forward group behind the wenpi decoction alcohol; G1 organizes (n=6): wenpi decoction decocting in water group (high dose); G2 organizes (n=8): wenpi decoction decocting in water group (low dosage); M organizes (n=10): model group; Z organizes (n=10): normal group; J organizes (n=10): sham operated rats (n=10).More than each treated animal sub-cage rearing, give the plain particles feedstuff and freely drink water.
1.4 experimental drug (seeing the following form).
Grouping of table 1 laboratory animal and medication
| Numbering | Quantity (n) | Medication | Dosage | Administration time (moon) |
| ?D | ????12 | Wenpi decoction CO 2The extraction preparation | ????0.25ml/100g | ????3 |
| ?E | ????12 | Wenpi decoction alcohol extraction preparation | ????1.0ml/100g | ????3 |
| ?F | ????12 | Water is obtained through refining agent behind the wenpi decoction alcohol | ????1.0ml/100g | ????3 |
| ?G1 | ????6 | Wenpi decoction decocting in water preparation (high dose) | ????2.0ml/100g | ????3 |
| ?G2 | ????8 | Wenpi decoction decocting in water preparation (low dosage) | ????1.0ml/100g | ????3 |
| M (model group) | ????10 | Normal saline | ????1.0ml/100g | ????3 |
| Z (normal group) | ????10 | Normal saline | ????1.0ml/100g | ????3 |
| J (sham operated rats) | ????10 | Normal saline | ????1.0ml/100g | ????3 |
1.5 inspection item
1.5.1 ordinary circumstance mental status, mobility, fur color and luster, ingest, body weight and survival rate etc.
1.5.2 blood biochemistry index detects serum creatinine (scr) with picric acid method, detects serum urea nitrogen (Bun) with the UV-GLDH method.
1.5.3 nephridial tissue om observation HE normal dyeing.
1.5.4 remaining kidney is observed quality, color, outward appearance, size.
2 experimental results:
2.1 the ordinary circumstance experimental session, the performance of normal control treated animal is alert, and reaction is fast, and the fur densification is neat and glossy, the equal Non Apparent Abnormality of growth, feed and active situation, and body weight increases gradually.The obvious malnutrition of modeling treated animal, listlessness, movable slow, inappetence, fur is fluffy, withered tarnish.Wherein obvious with model group, wenpi decoction is better than model group for all group.
2.2 it is as follows that the serum biochemistry index changes postoperative blood in March biochemical analysis result:
Table 2 wenpi decoction is to the influence of 5/6 nephrectomy kidney of rats function (postoperative April, treatment March)
Group quantity creatinine (mg/dl) blood urea nitrogen (mg/dl)
D??????????10????????1.26±0.24
ΔΔ??????34.14±5.15
ΔΔ
E??????????11????????0.94±0.10
**ΔΔ?????26.44±5.63
**Δ
F??????????12????????1.20±0.13
ΔΔ??????38.30±9.16
ΔΔ
G1?????????6?????????1.00±0.06
*ΔΔ?????26.20±2.27
**Δ
G2?????????8?????????1.07±0.12
ΔΔ??????25.09±6.06
**
M??????????9?????????1.17±0.17
ΔΔ??????37.68±6.28
ΔΔ
J??????????10????????0.77±0.09
**????????17.30±3.22
**
Z??????????10????????0.74±0.09
**????????19.52±2.95
**
Annotate: compare with model group
*P 0.05
*P 0.01
Compare Δ P 0.05 Δ Δ P 0.01 with normal group
Can reach a conclusion through above observation, no matter i.e. wenpi decoction decocting in water or the alcohol extraction preparation all has better curative effect to postponing chronic kidney function failure.Simultaneously, the result represents that wenpi decoction alcohol extraction preparation has better therapeutic on the progress of postponing chronic kidney function failure
Check the atrophy of the remaining kidney form of modeling group rat 2.3 remaining kidney general form is learned, quality is harder, and color is dim, and it is uneven that the surface is graininess, after cutting open along the longitudinal axis, sees that cortex part color is light red.The color of rats in normal control group kidney cortex, medullary substance, quality, form are normal fully.All the have clear improvement function of the renal tissue structural change that 5/6 nephrectomy caused of two kinds of preparation wenpi decoction groups is with alcohol extraction preparation group better efficacy.
2.4 the nephridial tissue light microscopy checking is got the kidney of every rat and is fixed with 40% formalin, do HE dyeing after the specimens paraffin embedding slices, as seen microscopically is observed: 5/6 nephrectomy animal glomerular capsule wall thickening, messangial cell vacuolation, fibrosis around the renal tubules hyaline cast, kidney small artery.All the have clear improvement function of the renal tissue structural change that 5/6 nephrectomy caused of two kinds of preparation wenpi decoction groups is with alcohol extraction preparation group better efficacy.
3, conclusion:
3.1 wenpi decoction is to the influence of renal function
The present invention's prompting, wenpi decoction has the effect that reduces chronic renal failure rat blood serum creatinine and blood urea nitrogen, and curative effect is sure.With the renal function contrast before the treatment, can find that equally this prescription has the effect of postponing chronic kidney function failure process.The effect of wenpi decoction postponing chronic kidney function failure process, mainly be to promote the eliminating of uremic toxins, promote proteinic synthetic, alleviate albuminuretic generation, and alleviate the inflammatory cell infiltration of matter between kidney and reduce the ill effect of cytokine, improve the local blood circulation of kidney, suppress the effect that mesangial cell proliferation and mesentery matrix components increase, delay the sclerosis of glomerule thereby reach.
3.2 wenpi decoction is to the influence of big excision of kidney of rats pathological change
Rat has hemodynamic change in the remaining nephron after the nephrectomy of big portion, cause that the height of remaining nephron filters, HT, finally can damage glomerule and cause glomerular sclerosis.The inventor finds in experiment, and the remaining kidney of wenpi decoction group rat has the increase of compensatory, and the remaining kidney of experiment contrast group rat obviously dwindles.The lesion degree of pathological section HE dyeing prompting wenpi decoction group rat kidney is lower than the experiment contrast group, results suggest, and wenpi decoction has the pathological change that alleviates remaining nephridial tissue, alleviates glomerular sclerosis, thereby has reached the effect of postponing chronic kidney function failure process.Clinical use can effectively reduce dialyse number of times and prolong dialysis blanking time of patient.
Embodiment 1
Radix Et Rhizoma Rhei 12kg, Radix Aconiti Lateralis Preparata 9kg, Rhizoma Zingiberis 6kg, Radix Ginseng 6kg, Radix Glycyrrhizae 3kg, 8 times of amounts of water decoct 3 times, merge the extracting solution of each time after, the cryoconcentration extracting solution gets extractum, contains crude drug 2g/ml, or system dry powder, paste-forming rate is 5～15%, is the wenpi decoction water extract.Get wenpi decoction dry powder 1000g, add medicinal dextrin 1000g, evenly mixed, alcohol granulation, tabletting makes 4000 in tablet.
Embodiment 2
Radix Et Rhizoma Rhei 12kg, Radix Aconiti Lateralis Preparata 9kg, Rhizoma Zingiberis 6kg, Radix Ginseng 6kg, Radix Glycyrrhizae 3kg use 80% ethanol, 8 times of amounts, extract 3 times, merge the extracting solution of each time after, recovered alcohol, get extractum, contain crude drug 2g/ml, or system dry powder, paste-forming rate is 5～15%, is the wenpi decoction alcohol extract, gets wenpi decoction dry powder 1000g, add medicinal dextrin 1000g, evenly mixed, alcohol granulation, encapsulated 5000, promptly.
Claims (7)
1, wenpi decoction preparation method of extract is characterized in that described extract is prepared by following method: Radix Et Rhizoma Rhei 3～20 weight portions; Radix Aconiti Lateralis Preparata 3～20 weight portions; Rhizoma Zingiberis 3～20 weight portions; Radix Ginseng 3～20 weight portions; Radix Glycyrrhizae 3～20 weight portions; 5～10 times of above-mentioned composition waters amount decocts 2-4 time, merge the extracting solution of each time after, the cryoconcentration extracting solution, extractum, contain crude drug 2g/ml, or make dry powder, paste-forming rate is 5～15%, is wenpi decoction water extract G and organizes; Above-mentioned composition extracts 2～4 times with 5～10 times of amounts of 40～90% ethanol, merge the extracting solution of each time after, recovered alcohol gets extractum, contains crude drug 2g/ml, or system dry powder, paste-forming rate is 5～15%, is wenpi decoction alcohol extract E group, 5～10 times of amounts of reuse water decoct 2-4 time after the alcohol extraction, merge the extracting solution of each time after, the cryoconcentration extracting solution gets extractum, contains crude drug 2g/ml, or system dry powder, paste-forming rate is 5～15%, is water extract F group behind the wenpi decoction alcohol; Above-mentioned composition extracts 2～4 times through CO2 extraction D group, merge the extracting solution of each time after, volatilize extractum, contain crude drug 2g/ml, or make dry powder, paste-forming rate is 1～5%.
2, the application of wenpi decoction compositions in the medicine of preparation treatment chronic renal failure.
3, the application of wenpi decoction compositions in the medicine of preparation reduction blood urea nitrogen, creatinine levels.
4, the application of wenpi decoction water extract in the medicine of preparation treatment chronic renal failure.
5, the application of wenpi decoction water extract in the medicine of preparation reduction blood urea nitrogen, creatinine levels.
6, the application of wenpi decoction alcohol extract in the medicine of preparation treatment chronic renal failure.
7, the application of wenpi decoction alcohol extract in the medicine of preparation reduction blood urea nitrogen, creatinine levels.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02103810 CN1232268C (en) | 2002-03-27 | 2002-03-27 | New use in medicine for compound decoction for warming spleen of Chinese herbal medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02103810 CN1232268C (en) | 2002-03-27 | 2002-03-27 | New use in medicine for compound decoction for warming spleen of Chinese herbal medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1446547A true CN1446547A (en) | 2003-10-08 |
| CN1232268C CN1232268C (en) | 2005-12-21 |
Family
ID=28048387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02103810 Expired - Fee Related CN1232268C (en) | 2002-03-27 | 2002-03-27 | New use in medicine for compound decoction for warming spleen of Chinese herbal medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1232268C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897942B (en) * | 2009-05-31 | 2012-02-08 | 北京四环科宝制药有限公司 | Method for detecting medicine composition for warming spleen and tonifying kidney and releasing turbidity and eliminating stasis |
| CN104225546A (en) * | 2014-09-26 | 2014-12-24 | 吕洁 | Traditional Chinese medicine for treating chronic renal failure |
| CN104740305A (en) * | 2015-04-10 | 2015-07-01 | 福建省第二人民医院 | Prescription with effects of nourishing kidney and reducing turbidity and preparation method thereof |
| CN116889589A (en) * | 2023-08-01 | 2023-10-17 | 上海中医药大学附属龙华医院 | Chinese herbal compound preparation for treating sepsis ARDS |
-
2002
- 2002-03-27 CN CN 02103810 patent/CN1232268C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897942B (en) * | 2009-05-31 | 2012-02-08 | 北京四环科宝制药有限公司 | Method for detecting medicine composition for warming spleen and tonifying kidney and releasing turbidity and eliminating stasis |
| CN104225546A (en) * | 2014-09-26 | 2014-12-24 | 吕洁 | Traditional Chinese medicine for treating chronic renal failure |
| CN104740305A (en) * | 2015-04-10 | 2015-07-01 | 福建省第二人民医院 | Prescription with effects of nourishing kidney and reducing turbidity and preparation method thereof |
| CN116889589A (en) * | 2023-08-01 | 2023-10-17 | 上海中医药大学附属龙华医院 | Chinese herbal compound preparation for treating sepsis ARDS |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1232268C (en) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102195547B1 (en) | Use of Cistanke Tubulosa Extract and Isoacteoside in Muscle Protection | |
| CN104042655A (en) | Application of Chinese herb Pien Tze Huang and preparation thereof in preparation of drugs for treating non-alcoholic fatty liver disease (NAFLD) | |
| CN114042146B (en) | Bovine bone peptide composition and application thereof in preparation of medicines for regulating intestinal flora and preventing and treating osteoporosis | |
| CN118178591A (en) | Traditional Chinese medicine composition for preventing and treating knee osteoarthritis and application thereof | |
| CN1232268C (en) | New use in medicine for compound decoction for warming spleen of Chinese herbal medicine | |
| CN102526346B (en) | Health-care pharmaceutical formulation with immunity-enhancing and senility-delaying functions | |
| CN102319256B (en) | Application of porphyra polysaccharide in preparing treatment medicament or prevention health-care product of kidney diseases | |
| CN102151284B (en) | Composition containing fucoidin sulfate and application thereof | |
| CN101485694B (en) | Method for extracting Ganoderma lucidum triterpenes components | |
| CN1181877C (en) | Medicine for curing diabetes and nephrosis and its preparing method | |
| CN111067933A (en) | Salvia miltiorrhiza extract and application thereof | |
| CN101054414B (en) | Method of extracting and preparing deer DGF | |
| CA2494744A1 (en) | Use of fermented wheat germ extract as anti-inflammatory agent | |
| CN101528251A (en) | Agent comprising G-CSF for prevention and treatment of diabetic peripheral neuropathy | |
| CN1195529C (en) | Composition containing muscle-derived active agents | |
| EP4248964A1 (en) | Pharmaceutical composition for treating sepsis, and use thereof | |
| KR20040003888A (en) | Composition of crude drug, method of preparing the same and pharmaceutical preparation including the same for curing diabetes mellitus | |
| TWI526217B (en) | Cyanobacterial extract solution, pharmaceutical composition and use thereof | |
| CN110123871B (en) | Traditional Chinese medicine composition preparation for improving leucocyte and expelling toxin and preparation method thereof | |
| CN112870250B (en) | Composition for preventing and treating organ fibrosis and application and preparation thereof | |
| CN114949022B (en) | Traditional Chinese medicine composition for treating tumors | |
| CN113116929B (en) | Cell-free fat extract for treating fatty liver and its complications | |
| CN100339133C (en) | Composition of nanometer SOD and astragalus root or its extract and its preparation method | |
| CN100336526C (en) | Medicine composition for treating diabetes and preparing method | |
| CN1075949C (en) | Auxiliary medicine for curing tumor, its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051221 Termination date: 20110327 |